Tag: Misconception

Tesamorelin, marketed under brand names like Egrifta WR, is not banned and remains an FDA-approved treatment for HIV-associated lipodystrophy. The persistent question of "Why was tesamorelin banned?" stems from regulatory events and confusion surrounding different formulations and international market applications. This article clarifies the drug's true regulatory history.

Despite common online searches, Topamax (topiramate) is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA). The question, 'Why is Topamax a controlled substance?', arises from a misunderstanding often linked to combination medications or a confusion about its prescription-only status.